Share 'News from World Muscle Society: Days 2 & 3'
PTC Therapeutics Symposium – “Improving Outcomes for the Future: Making sense of the nonsense mutations in Duchenne muscular dystrophy”
PTC Therapeutics gave an overview of the data supporting the recent accelerated approval for Translarna® in Europe and answered questions from prescribing physicians about how the medication should be used.
Dr. Eugenio Mercuri first described how the results…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this